SpecGx LLC FDA Inspection Record
SpecGx LLC is an FDA-registered facility (FEI 1317295) located in Hobart, NY, US. Registered operations: ANALYSIS; DISTRIBUTE; MANUFACTURE; PACK; RELABEL; REPACK. RegDataLab tracks 6 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Mar 13, 2020: No Action Indicated (NAI)
- Inspections on record
- 6 (4 VAI, 2 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 3, latest May 25, 2012
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Mar 13, 2020 | No Action Indicated (NAI) | No citations listed |
| Apr 6, 2018 | No Action Indicated (NAI) | No citations listed |
| Jan 29, 2016 | Voluntary Action Indicated (VAI) | Storage under appropriate conditions (21 CFR 211.142(b)) Accurate reproduction included (21 CFR 211.188(a)) |
| Aug 30, 2013 | Voluntary Action Indicated (VAI) | SOPs not followed / documented (21 CFR 211.100(b)) Establishment of time limitations (21 CFR 211.111) Approval and review of procedures (21 CFR 211.100(a)) |
| Apr 20, 2012 | Voluntary Action Indicated (VAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a)) Establishment of time limitations (21 CFR 211.111) Sanitation--buildings not clean, free of infestation (21 CFR 211.56(a)) and 2 more |
| Jan 27, 2010 | Voluntary Action Indicated (VAI) | Clothing appropriate for duties performed (21 CFR 211.28(a)) Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a)) Buildings not maintained in good state of repair (21 CFR 211.58) Written warehousing procedures established/followed (21 CFR 211.142) |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| May 25, 2012 | Class II | D-1430-2012 | Hydrocodone Bitartrate and Acetaminophen Oral Solution, 7.5 mg/500 mg per 15 mL, 16 fl oz… and 1 more product Subpotent (Multiple Ingredient) Drug: Low out of specification assay results for the hydrocodone bitartrate ingredient was found. |
| Mar 15, 2012 | Class III | D-1358-2012 | Methylin Chewable Tablets (methylphenidate HCl) 2.5 mg, 100 count bottle, Rx only… and 2 more products Stability Data does not Support Expiration Date: Covidien Mallinckrodt Inc. is conducting a voluntary recall of Methylin Chewable Tablets… |
| Jan 14, 2004 | Class II | D-105-4 | Oxycodone Hydrochloride Oral Concentrate Solution, 20 mg/mL, 30 mL bottle, Rx only… Defective Dropper; the ink graduated markings dissolve when stored in the product which may result in inaccurate administration of… |
FDA record score
0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
6 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Jan 29, 2016 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Aug 30, 2013 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1430-2012, this FEI as the recalling firm | May 25, 2012 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Apr 20, 2012 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jan 27, 2010 | 10 years or older, so it adds no points | 0 |
| Class II recall D-105-4, this FEI as the recalling firm | Jan 14, 2004 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing SpecGx LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check SpecGx LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- SpecGx LLC
- Location
- Hobart, NY (US)
- Registration Expires
- Dec 31, 2027
- Operations
- ANALYSIS; DISTRIBUTE; MANUFACTURE; PACK; RELABEL; REPACK
- Source
- decrs